The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan

Biomaterials

Volumn 32, Issue 1, 2011, Pages 75-86

  Tang, Zack C W ^a   Liao, Wei Yin ^a   Tang, Alan C L ^a   Tsai, Shih Jung ^b   Hsieh, Patrick C H ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Angiogenesis; Endothelial cell; Hyaluronan; Peripheral artery occlusive disease

Indexed keywords

ANGIOGENESIS; APOPTOSIS; ARTERIAL DISEASE; ARTERIOGENESIS; BLOOD PERFUSION; CELL THERAPY; CLINICAL THERAPY; DIRECT INJECTION; ENGRAFTMENT; FEMORAL ARTERY; HIND LIMBS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HYALURONAN; ISCHEMIC INJURIES; ISCHEMIC LIMBS; MOUSE MODELS; OCCLUSIVE DISEASE; PERIPHERAL ARTERIES; RETENTION RATE; THERAPEUTIC ANGIOGENESIS; TRANSPLANTED CELLS; VASCULATURE;

ANIMALS; CELL CULTURE; CELL DEATH; DISEASE CONTROL; SELF ASSEMBLY;

ENDOTHELIAL CELLS;

ENHANCED GREEN FLUORESCENT PROTEIN; GELATIN; HYALURONIC ACID;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CELL VIABILITY; CONTROLLED STUDY; DOPPLER FLOWMETRY; ENDOTHELIUM CELL; HINDLIMB; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIMB ISCHEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; UMBILICAL VEIN; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ARTERIES; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HINDLIMB; HUMANS; HYALURONIC ACID; INJECTIONS; ISCHEMIA; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; ORGANOGENESIS; TISSUE THERAPY; TREATMENT OUTCOME; UMBILICAL VEINS;

ANIMALIA; MUS;

EID: 78349309236     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.085     Document Type: Article

References (31)

1. Hirsch A.T., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., Hiratzka L.F., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease. Circulation 2006, 113:e463-e654.
2. Kong D., Melo L.G., Gnecchi M., Zhang L., Mostoslavsky G., Liew C.C., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004, 110:2039-2046.
3. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116:2409-2419.
4. Krenning G., van Luyn M.J., Harmsen M.C. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 2009, 15:180-189.
5. Kawamoto A., Katayama M., Handa N., Kinoshita M., Takano H., Horii M., et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 2009, 27:2857-2864.
6. Franz R.W., Parks A., Shah K.J., Hankins T., Hartman J.F., Wright M.L. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease. J Vasc Surg 2009, 50:1378-1390.
7. Amann B., Luedemann C., Ratei R., Schmidt-Lucke J.A. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 2009, 18:371-380.
8. Lara-Hernandez R., Blanes P., Torreguitart-Mirada N., Galmés A., Besalduch J. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia. Ann Vasc Surg 2010, 24:287-294.
9. Segers V.F.M., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
10. Ozawa C.R., Glazer N.L., Thurston G., Springer M.L., Kraft P.E., McDonald D.M., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004, 113:516-527.
11. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004, 95:9-20.
12. Li Z., Wu J.C., Sheikh A.Y., Kraft D., Cao F., Xie X., et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007, 116:I46-I54.
13. Sheikh A.Y., Cao F., Cao Y., van der Bogt K.E., Chu P., Chang C.P., et al. Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells 2007, 25:2677-2684.
14. Silva E.A., Kim E.S., Kong H.J., Mooney D.J. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A 2008, 105(38):14347-14352.
15. Callegari A., Bollini S., Iop L., Chiavegato A., Torregrossa G., Pozzobon M., et al. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 2007, 28:5449-5461.
16. Lei P., Padmashali R.M., Andreadis S.T. Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 2009, 30:3790-3799.
17. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396.
18. Kimura Y., Tabata Y. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed. 2010, 21:37-51.
19. Evanko S.P., Tammi M.I., Tammi R.H., Wight T.N. Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev. 2007, 59:1351-1365.
20. Oh E.J., Kim K.S., Kim J., Yang J.A., Kong J.H., Lee M.Y., et al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release 2010, 141:2-12.
21. Hayen W., Goebeler M., Kumar S., Riessen R., Nehls V. Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci. 1999, 112(Pt 13):2241-2251.
22. Hoffman A.S. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002, 54:3-12.
23. Toole B.P., Wight T.N., Tammi M.I. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem. 2002, 277:4593-4596.
24. Baudin B., Bruneel A., Bosselut N., Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2007, 2:481-485.
25. Swijnenburg R.J., Tanaka M., Vogel H., Baker J., Kofidis T., Gunawan F., et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005, 112:S166-S172.
26. Methe H., Hess S., Edelman E.R. Endothelial cell-matrix interactions determine maturation of dendritic cells. Eur J Immunol 2007, 37:1773-1784.
27. Methe H., Edelman E.R. Cell-matrix contact prevents recognition and damage of endothelial cells in states of heightened immunity. Circulation 2006, 114:I233-I238.
28. Methe H., Groothuis A., Sayegh M.H., Edelman E.R. Matrix adherence of endothelial cells attenuates immune reactivity: induction of hyporesponsiveness in allo- and xenogeneic models. FASEB J 2007, 21:1515-1526.
29. Papapetropoulos A., Fulton D., Mahboubi K., Kalb R.G., O'Connor D.S., Li F., et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem. 2000, 275:9102-9105.
30. 2-terminal kinase and caspase-3. Circulation 2000, 101(22):2618-2624.
31. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395.